GLP-1s can slow gastric emptying, helping patients feel fuller for longer periods, which can reduce overall calorie intake
LGG stimulates the production of secretory IgA, an antibody that plays a frontline defense role in the gut and respiratory tract
However, several data points help explain just how widespread the issue appears to be: Clinical Trial Data : In Novo Nordisk clinical trials, about 9% of patients reported frequent burping (officially known as eructation)a wellknown pathway for odor to reach the breath
GPR119, a major enteroendocrine sensor of dietary triglyceride metabolites coacting in synergy with FFA1 (GPR40)
Instead of highlighting rapid results or aggressive dose escalation, the program focuses on supporting metabolic health, energy, inflammation response, and overall vitality through lower-than-standard GLP-1 doses
GLP-1 receptor agonism reduces appetite, slows gastric emptying, increases glucose-dependent insulin secretion, and suppresses glucagon